Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kulkarni Samarth Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Kulkarni Samarth (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns: Granted 27,200 options to buy @ $11.66, valued at $317.2k
06/01/2023 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 7,301 shares @ $63.6149, valued at $464.5k
Sold 5,999 shares @ $64.4577, valued at $386.7k
Sold 9,300 shares @ $65.63, valued at $610.4k
Sold 2,400 shares @ $66.8338, valued at $160.4k
Exercised 25,000 options to buy @ $19.12, valued at $478k
05/30/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 4 Kulkarni Samarth (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 144 Form 144 - Report of proposed sale of securities:
03/31/2023 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 19,719 shares @ $44.3733, valued at $875k
Sold 5,281 shares @ $44.7844, valued at $236.5k
Exercised 25,000 options to buy @ $19.12, valued at $478k
03/14/2023 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Paid exercise price by delivering 5,358 shares @ $43.22, valued at $231.6k
Paid exercise price by delivering 4,086 shares @ $43.22, valued at $176.6k
Exercised 11,833 restricted stock units @ $0
Granted 188,000 options to buy @ $43.22, valued at $8.1M
Granted 77,000 restricted stock units @ $0
Exercised 9,000 restricted stock units @ $0
03/01/2023 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 10,180 shares @ $47.7122, valued at $485.7k
Sold 13,720 shares @ $48.5725, valued at $666.4k
Sold 1,100 shares @ $49.1986, valued at $54.1k
Exercised 25,000 options to buy @ $19.12, valued at $478k
02/22/2023 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Paid exercise price by delivering 6,373 shares @ $48.26, valued at $307.6k
Exercised 13,250 restricted stock units @ $0
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2022 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 23,200 shares @ $64.5782, valued at $1.5M
Sold 1,800 shares @ $64.97, valued at $116.9k
Exercised 25,000 options to buy @ $16.21, valued at $405.3k
08/31/2022 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 4,073 shares @ $66.1405, valued at $269.4k
Sold 20,764 shares @ $66.975, valued at $1.4M
Sold 163 shares @ $67.64, valued at $11k
Exercised 25,000 options to buy @ $16.21, valued at $405.3k
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2022 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 6,933 shares @ $75.6385, valued at $524.4k
Sold 700 shares @ $76.373, valued at $53.5k
Sold 700 shares @ $77.7929, valued at $54.5k
Sold 12,759 shares @ $75.732, valued at $966.3k
Sold 3,308 shares @ $76.2944, valued at $252.4k
Sold 600 shares @ $77.9717, valued at $46.8k
Exercised 8,333 options to buy @ $12.57, valued at $104.7k
Exercised 16,667 options to buy @ $16.21, valued at $270.2k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Kulkarni Samarth (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $2.14, valued at $32.1k
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Paid exercise price by delivering 5,487 shares @ $62.56, valued at $343.3k
Paid exercise price by delivering 4,153 shares @ $61.08, valued at $253.7k
Exercised 11,834 restricted stock units @ $0
Exercised 9,000 restricted stock units @ $0
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2021 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Exercised 17,750 options to buy @ $1.81, valued at $32.1k
12/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2021 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 43,000 options to buy @ $97, valued at $4.2M
Exercised 33,000 options to buy @ $1.81, valued at $59.7k
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/06/2021 4 Kulkarni Samarth (CEO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 1,500 shares @ $125.02, valued at $187.5k
Sold 1,000 shares @ $126.67, valued at $126.7k
Sold 4,700 shares @ $127.82, valued at $600.8k
Sold 13,499 shares @ $128.85, valued at $1.7M
Sold 6,819 shares @ $129.82, valued at $885.2k
Sold 2,482 shares @ $130.51, valued at $323.9k
Exercised 1,500 options to buy @ $12.57, valued at $18.9k
Exercised 28,500 options to buy @ $12.57, valued at $358.2k
06/22/2021 4 Kulkarni Samarth (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $12.55, valued at $188.3k
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy